Purchase Order 75F40121P00040

Award Date 3/8/21
Potential Completion Date 4/14/25
Potential Value $259K
Ultimate Awardee
Bio-Techne Corporation
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95134, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Office of Product Quality and Research (OPQR) has awarded a firm-fixed-price Purchase Order to Proteinsimple, a division of Bio-Techne Corporation, to provide replacement parts and components for the agency's ProteinSimple CE-SDS/cIEF (Maurice) protein characterization and analysis system. The $38,269.69 contract has a completion date of September 30, 2024 and does not utilize a set-aside designation....
This is a $78,500.00 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency under the Department of Health and Human Services (HHS), to Proteinsimple, also known as Bio-Techne Corporation Division. The contract is for the provision of a robotic automatic instrument, which is a specialized protein analysis product. The contract has a total small business set-aside designation. Proteinsimple, a for-profit manufacturer of goods, has...
The U.S. Food and Drug Administration (FDA) awarded a $75,974.00 firm fixed-price purchase order to Proteinsimple, a subsidiary of Bio-Techne Corporation, to provide an instrument capable of performing single cell Western blot analyses. This specialized equipment is essential to support ongoing FDA projects that require analyzing regulatory samples and ascertaining protein expression heterogeneity within cell populations. The contract did not utilize any set-aside designations and was awarded...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $287,976.64 firm fixed price purchase order to Molecular Devices, LLC for a BLI Detection System. As a prime contractor, Molecular Devices will deliver the requested detection system to support HHS FDA programs. Performance will occur at Molecular Devices' San Jose, California location from March 2020 through August 2020. No set aside designation or subcontractors were indicated. The award provides the...
The United States Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grants Services has awarded a $605,098.90 firm fixed price purchase order to Molecular Devices LLC, a division of Danaher Corporation, to provide a High Content Screening System under solicitation FDA-RFQ-75F40123Q00015-CFSAN-2023-114792. The place of performance will be Molecular Devices LLC's facilities located in San Jose, California. The period of performance is from January 12,...
This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services, to Proteinsimple (a division of Bio-Techne Corporation) for the procurement of a FluorChem E system. The award, valued at $21,750.00, does not have a set-aside designation. Proteinsimple is a leading manufacturer of protein analysis products and services, and this contract supports the agency's...
The Food and Drug Administration (FDA) awarded a $947,868.05 firm-fixed-price purchase order to Government Scientific Source Inc., a small business, for the delivery of a high-resolution ion mobility-high resolution mass spectrometer (HRIM-HRMS) system. This system will expand the FDA's analytical capabilities for ensuring the safety and efficacy of complex drugs like biologics, peptides, and oligonucleotides. The contract has a completion date of January 31, 2024 and includes training,...
The Department of Health and Human Services Food and Drug Administration awarded a $786,769.86 firm fixed price delivery order against the Thermo Electron Corporation Financial Services Division's Multiple Award Schedule contract. The order is for the purchase of a high resolution mass spectrometer coupled with a dual liquid chromatography system from Thermo Electron North America LLC, along with an optional four-year service agreement. Performance will take place in St. Louis, Missouri...
This is a $22,950.00 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Proteinsimple, a small business manufacturer of biomedical research products and services. The contract is for the delivery of a FLUORCHEM E SYSTEM, including shipping and handling. This award was issued under a total small business set-aside. Proteinsimple has previously served as both a prime contractor and subcontractor on various federal contracts to...
This is a $79,530.23 firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Thermo Electron North America LLC, a for-profit limited liability company. The contract is to provide a new ultra-high performance liquid chromatography (UHPLC) system with a refractive index detector to support the FDA's San Francisco laboratory in conducting nutrient analysis, specifically to analyze sugar content in food products and dietary supplements in accordance with the approved...

The U.S. Food and Drug Administration, Office of Acquisition and Grants Services has awarded a firm fixed price purchase order to Proteinsimple of San Jose, California for $258,748.08. The award is to procure a "Maurice System" capable of performing capillary isoelectric focusing and capillary electrophoresis, as requested in the original solicitation to support the FDA's regulatory and research initiatives. Proteinsimple, a manufacturer and provider of protein analysis products and services, will deliver the equipment from its location in San Jose. There is no set-aside designation associated with this purchase order issued by the Department of Health and Human Services' FDA.

Generated 1/28/24, 12:20 AM